Zmks International Cancer Therapy Biotechnologies Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Zmks International Cancer Therapy Biotechnologies General Information
Description
Develops and manufacturer of cancer treatment technology and equipment intended for cancer treatment. The company's technology and equipment include cancer stem cell technology, tumor immune cell therapy, gene therapy techniques, molecular targeted cancer therapy, minimally invasive and non-invasive treatment technologies, enabling patients to get immediate ailment for cancer.
Contact Information
Website
www.zmksbiotech.comCorporate Office
- Shenzhen
- China
Corporate Office
- Shenzhen
- China
Zmks International Cancer Therapy Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zmks International Cancer Therapy Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zmks International Cancer Therapy Biotechnologies FAQs
-
When was Zmks International Cancer Therapy Biotechnologies founded?
Zmks International Cancer Therapy Biotechnologies was founded in 2008.
-
Where is Zmks International Cancer Therapy Biotechnologies headquartered?
Zmks International Cancer Therapy Biotechnologies is headquartered in Shenzhen, China.
-
What industry is Zmks International Cancer Therapy Biotechnologies in?
Zmks International Cancer Therapy Biotechnologies’s primary industry is Biotechnology.
-
Is Zmks International Cancer Therapy Biotechnologies a private or public company?
Zmks International Cancer Therapy Biotechnologies is a Private company.
-
What is the current valuation of Zmks International Cancer Therapy Biotechnologies?
The current valuation of Zmks International Cancer Therapy Biotechnologies is .
-
What is Zmks International Cancer Therapy Biotechnologies’s current revenue?
The current revenue for Zmks International Cancer Therapy Biotechnologies is .
-
When was Zmks International Cancer Therapy Biotechnologies acquired?
Zmks International Cancer Therapy Biotechnologies was acquired on 11-Sep-2014.
-
Who acquired Zmks International Cancer Therapy Biotechnologies?
Zmks International Cancer Therapy Biotechnologies was acquired by Beijing Beilu Pharmaceutical Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
